Notify me when Logos Global Management LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PTNT | PALATIN TECHNOLOGIES INC | Common Stock | 9.9% | $1.46M | 142K | Logos Global Management LP | 06 Nov 2025 | ||
| IBIO | iBio, Inc. | Common Stock | 8.9% | $2.4M | 2M | Logos Global Management LP | 12 Dec 2025 | ||
| ERAS | Erasca, Inc. | Common Stock | 4.8% | $29.6M | -$3.27M | 13.6M | -9.93% | Logos Global Management LP | 30 Sep 2025 |
| VSTM | Verastem, Inc. | Common Stock | 4.8% | $28M | -$2.21M | 3.18M | -7.3% | Logos Global Management LP | 30 Sep 2025 |
| OLMA | Olema Pharmaceuticals, Inc. | Common Stock | 4.7% | $16.2M | 3.21M | Logos Global Management LP | 18 Mar 2025 | ||
| DSGN | Design Therapeutics, Inc. | Common Stock | 4.4% | $16.3M | -$4.8M | 2.52M | -22.7% | Arsani William | 14 Nov 2025 |
| CBIO | CRESCENT BIOPHARMA, INC. | Ordinary Shares | 4.1% | $7.76M | 575K | Logos Global Management LP | 30 Jun 2025 | ||
| ARVN | ARVINAS, INC. | Common Stock ("Stock") | 3.4% | $21.3M | -$32.4M | 2.5M | -60.3% | Logos Global Management LP | 13 Oct 2025 |
| NXTC | NextCure, Inc. | Common Stock | 0% | $0 | 0 | Logos Global Management LP | 31 Dec 2024 | ||
| ELEV | Elevation Oncology, Inc. | Common Stock | 0% | $0 | 0 | Logos Global Management LP | 31 Dec 2024 | ||
| ANNX | Annexon, Inc. | Common Stock | 0% | $0 | -$17M | 0 | -100% | Logos Global Management LP | 30 Jun 2025 |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Ordinary Shares | 0% | $0 | -$18.6M | 0 | -100% | Logos Global Management LP | 30 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|